338 related articles for article (PubMed ID: 22058153)
41. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
[TBL] [Abstract][Full Text] [Related]
42. Familial aggregation of genetically heterogeneous hypertrophic cardiomyopathy: a boy with LEOPARD syndrome due to PTPN11 mutation and his nonsyndromic father lacking PTPN11 mutations.
Digilio MC; Pacileo G; Sarkozy A; Limongelli G; Conti E; Cerrato F; Marino B; Pizzuti A; Calabrò R; Dallapiccola B
Birth Defects Res A Clin Mol Teratol; 2004 Feb; 70(2):95-8. PubMed ID: 14991917
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
[TBL] [Abstract][Full Text] [Related]
44. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.
Pandit B; Sarkozy A; Pennacchio LA; Carta C; Oishi K; Martinelli S; Pogna EA; Schackwitz W; Ustaszewska A; Landstrom A; Bos JM; Ommen SR; Esposito G; Lepri F; Faul C; Mundel P; López Siguero JP; Tenconi R; Selicorni A; Rossi C; Mazzanti L; Torrente I; Marino B; Digilio MC; Zampino G; Ackerman MJ; Dallapiccola B; Tartaglia M; Gelb BD
Nat Genet; 2007 Aug; 39(8):1007-12. PubMed ID: 17603483
[TBL] [Abstract][Full Text] [Related]
45. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
46. Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347291
[TBL] [Abstract][Full Text] [Related]
47. Low-dose dasatinib rescues cardiac function in Noonan syndrome.
Yi JS; Huang Y; Kwaczala AT; Kuo IY; Ehrlich BE; Campbell SG; Giordano FJ; Bennett AM
JCI Insight; 2016 Dec; 1(20):e90220. PubMed ID: 27942593
[TBL] [Abstract][Full Text] [Related]
48. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.
Foltz SJ; Luan J; Call JA; Patel A; Peissig KB; Fortunato MJ; Beedle AM
Skelet Muscle; 2016; 6():20. PubMed ID: 27257474
[TBL] [Abstract][Full Text] [Related]
49. Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity.
Ruggiero A; Chen SN; Lombardi R; Rodriguez G; Marian AJ
Cardiovasc Res; 2013 Jan; 97(1):44-54. PubMed ID: 22987565
[TBL] [Abstract][Full Text] [Related]
50. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene.
Nakaoka Y; Shioyama W; Kunimoto S; Arita Y; Higuchi K; Yamamoto K; Fujio Y; Nishida K; Kuroda T; Hirota H; Yamauchi-Takihara K; Hirano T; Komuro I; Mochizuki N
J Mol Cell Cardiol; 2010 Aug; 49(2):157-64. PubMed ID: 20226789
[TBL] [Abstract][Full Text] [Related]
51. Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.
Kim M; Hunter RW; Garcia-Menendez L; Gong G; Yang YY; Kolwicz SC; Xu J; Sakamoto K; Wang W; Tian R
Circ Res; 2014 Mar; 114(6):966-75. PubMed ID: 24503893
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular disease in Noonan syndrome.
Pierpont ME; Digilio MC
Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
[TBL] [Abstract][Full Text] [Related]
53. Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations.
Calcagni G; Digilio MC; Marino B; Tartaglia M
Orphanet J Rare Dis; 2019 Jul; 14(1):163. PubMed ID: 31277675
[TBL] [Abstract][Full Text] [Related]
54. Shp2 in myocytes is essential for cardiovascular and neointima development.
Gong H; Ni J; Xu Z; Huang J; Zhang J; Huang Y; Zeng C; Zhang X; Cheng H; Ke Y
J Mol Cell Cardiol; 2019 Dec; 137():71-81. PubMed ID: 31634485
[TBL] [Abstract][Full Text] [Related]
55. Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy.
Huang Y; Lu H; Ren X; Li F; Bu W; Liu W; Dailey WP; Saeki H; Gabrielson K; Abraham R; Eckenhoff R; Gao WD
Cardiovasc Res; 2020 May; 116(6):1175-1185. PubMed ID: 31424496
[TBL] [Abstract][Full Text] [Related]
56. LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity.
Tajan M; Batut A; Cadoudal T; Deleruyelle S; Le Gonidec S; Saint Laurent C; Vomscheid M; Wanecq E; Tréguer K; De Rocca Serra-Nédélec A; Vinel C; Marques MA; Pozzo J; Kunduzova O; Salles JP; Tauber M; Raynal P; Cavé H; Edouard T; Valet P; Yart A
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4494-503. PubMed ID: 25288766
[TBL] [Abstract][Full Text] [Related]
57. Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.
Jaffré F; Miller CL; Schänzer A; Evans T; Roberts AE; Hahn A; Kontaridis MI
Circulation; 2019 Jul; 140(3):207-224. PubMed ID: 31163979
[TBL] [Abstract][Full Text] [Related]
58. Activation of Autophagy Ameliorates Cardiomyopathy in
Singh SR; Zech ATL; Geertz B; Reischmann-Düsener S; Osinska H; Prondzynski M; Krämer E; Meng Q; Redwood C; van der Velden J; Robbins J; Schlossarek S; Carrier L
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021349
[TBL] [Abstract][Full Text] [Related]
59. SHP2 sails from physiology to pathology.
Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
[TBL] [Abstract][Full Text] [Related]
60. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
